Korean Market
OWNR
OliX Pharmaceuticals
★

OliX Non-Registered Director Exercises Stock Purchase Rights, Slightly Increases Stake

 
OWNR
OliX Pharmaceuticals
★

Executive Park Jun-hyun Increases Stake by 1,000 Shares Through Exercise of Stock Purchase Rights (3,000 shares at 18,050 won) and Open Market Sale (2,000 shares at 167,300 won), Ownership Rises from 0.03% to 0.04%

 
EXCH
OliX Pharmaceuticals
★

Record Date Set for Extraordinary General Meeting to Determine Shareholder Rights, No Direct Impact on Shareholder Value

 
MATR
OliX Pharmaceuticals
★★

OliX Pharmaceuticals raises 110.8 billion KRW via 740,367-share third-party allotment at 10% discount; L'Oreal affiliate participation strengthens strategic partnership, offsetting dilution with growth prospects

 
OWNR
OliX Pharmaceuticals
★

Largest Shareholder Dong-gi Lee's Stake Slightly Decreases from 17.14% to 16.93% Due to Off-Market Sales and Executive Resignation

 
OWNR
OliX Pharmaceuticals
★★

OliX CEO Dong-gi Lee Sells 33,333 Shares in Block Trade at 14.6% Discount, Stake Drops to 14.94%, Raising Concerns

 
PERI
OliX Pharmaceuticals
★★

Olix Q1 2026 Revenue KRW 3.57B... Lilly & Hansoh Tech Transfer Deals on Track